Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Learn which credit card offers the best rewards for travel and how to choose one that fits your travel needs. Start maximizing your trips.
27,921 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Bay Area housing shows a stark split: luxury homes surge on AI-era wealth, while affordable properties slip. Analysts...
As GBTC’s 1.50% fee persists, the cost compounds for long-horizon investors. This piece compares the drag to cheaper ...
As the AI rally fans the markets, the boom looks like dot-com. Yet Bitcoin bulls point to a tangible edge—scarcity an...
UnitedHealth stock quietly soared about 80% off its 2025 low, signaling a meaningful rebound. This article dives into...
A key Senate markup on the CLARITY Act is slated for May 14, with a handful of Democrats deciding whether the bill ad...
Volkswagen signals a smarter-cost strategy to turn around its performance, prioritizing efficiency over plant shutdow...
A startup founded apple vets by former Apple executives has raised $241 million without a single customer, underscori...
Meta quietly positions itself as the strongest mega-cap alternative this summer, leveraging ad momentum and a new AI ...
Two giants in the U.S. cannabis space face off for investors: Green Thumb Industries and Curaleaf. This guide breaks ...
The market is hovering around record levels, but does that mean you should sit on the sidelines? Not necessarily. Thi...
As inflation and market volatility persist into 2026, two smart social security claiming strategies help married coup...